Mark J Casey
CIK 1415297 · EVP, Chief Legal Officer · last filed 2026-03-09
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$799.8K
Companies
4
Total Filings
54
Lifetime Open-Market Net
-$3.73M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NVAX | EVP, Chief Legal Officer | 90,067 | $8.88 | $799.8K | $0 | 9 | 2026-03-09 |
| Keenova Therapeutics plc (MNK) Delisted | EVP & Chief Legal Officer | 0 | $0.34 | $0 | -$6.9K | 9 | 2022-06-21 |
| Aceragen, Inc. (IDRA) Delisted | Senior VP & General Counsel | 34,450 | $7.22 | $248.9K | $49.6K | 5 | 2018-01-05 |
| HOLOGIC INC (HOLX) Delisted | SVP, CAO, GC & Secretary | 15,816 | $76.01 | $1.20M | -$3.77M | 31 | 2014-11-19 |
Recent Filings · Page 2 of 6
54 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-12-18 | Keenova Therapeutics plc (MNK) Delisted | Sell (S) | −15,291 | -$6.9K | EDGAR |
| 2020-04-03 | Keenova Therapeutics plc (MNK) Delisted | Tax (F) | −3,572 | -$6.6K | EDGAR |
| 2020-02-04 | Keenova Therapeutics plc (MNK) Delisted | Tax (F) | −1,252 | -$5.7K | EDGAR |
| 2019-04-05 | Keenova Therapeutics plc (MNK) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-04-03 | Keenova Therapeutics plc (MNK) Delisted | Mixed | +14,961 | -$48.1K | EDGAR |
| 2019-02-05 | Keenova Therapeutics plc (MNK) Delisted | Tax (F) | −1,248 | -$27.9K | EDGAR |
| 2018-04-04 | Keenova Therapeutics plc (MNK) Delisted | Grant (A) | +24,638 | $0 | EDGAR |
| 2018-02-05 | Keenova Therapeutics plc (MNK) Delisted | Grant (A) | +13,775 | $0 | EDGAR |
| 2018-01-05 | Aceragen, Inc. (IDRA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-01-06 | Aceragen, Inc. (IDRA) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.